Search
for
Sort by
Research 961–990 of 1000+
- Dihydrotestosterone and 5α-Reductase
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- Estrogen and androgen signaling in the pathogenesis of BPH
- Steroid 5α-reductases and 3α-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism
- Endocrine control of benign prostatic hyperplasia
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- The enzyme and inhibitors of 4-ene-3-oxosteroid 5α-oxidoreductase
- Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia
- A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms.
- Natural variability and the influence of concurrent control values on the detection and interpretation of low-dose or weak endocrine toxicities.
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Hepatotoxicity Complicating Flutamide Treatment of Hirsutism
- Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.
- Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.
- Post-finasteride syndrome: An emerging clinical problem
- Dihydrotestosteron und die Rolle der 5α-Reduktasehemmer bei der benignen Prostatahyperplasie
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Design, Synthesis and Evaluation of N13-Substituted Evodiamine Derivatives against Human Cancer Cell Lines
- Interaction of spironolactone with rat skin androgen receptor
- New Progesterone Esters as 5.ALPHA.-Reductase Inhibitors.
- 5α‐Reductase inhibitors and prostatic disease
- Medikamentöse Therapie des benignen Prostatasyndroms
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- 12-Chloracetyl-PPD, a novel dammarane derivative, shows anti-cancer activity via delay the progression of cell cycle G2/M phase and reactive oxygen species-mediate cell apoptosis
- Hormonal manipulation of benign prostatic hyperplasia
- Structural characterization of polymorphs and molecular complexes of finasteride
- Saturable Binding of Finasteride to Steroid 5α-reductase as Determinant of Nonlinear Pharmacokinetics
- Biological activity of novel progesterone derivatives having a bulky ester side chains at C-3
- Finasteride-Induced Gynecomastia in a 62-Year-Old Man
- Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice